EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines

Epidermal growth factor receptor (EGFR) is one of therapeutic targets in oncology for solid tumors originating from epithelial tissue, such as non-small-cell lung carcinoma (NSCLC) and breast cancer. EGFR inhibitors used in cancer treatment may cause a broad spectrum of dose-dependent cutaneous adve...

Descripción completa

Detalles Bibliográficos
Autores principales: Nowaczyk, Joanna, Fret, Kamil, Kaminska-Winciorek, Grazyna, Rudnicka, Lidia, Czuwara, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414157/
https://www.ncbi.nlm.nih.gov/pubmed/36708507
http://dx.doi.org/10.1097/CAD.0000000000001494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414157/
https://www.ncbi.nlm.nih.gov/pubmed/36708507
http://dx.doi.org/10.1097/CAD.0000000000001494

Ejemplares similares